Kenya Sickel Cell Disease Market Analysis


  • Type: Common Disease Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4834

  • Format: PPT, PDF

Kenya Sickle Cell Disease Drug Market: Segmented by Drug Class (Anti-metabolites and Monoclonal Antibodies), Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies and Others)- Growth, Trends, and Forecasts (2019 – 2028)

SKU: 4834 Categories: ,

Report Overview

The Kenya sickle cell drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

The Kenyan market for sickle cell disease treatment has been expanding alongside growing need for treating diseases related to blood plasma. Sickle cell disease (SCD) is the most common hemoglobinopathy encountered in Kenya. In the western part of the country, about 4.5% of children are born with SCD, and 18% of children are born with sickle cell trait.  It is estimated that approximately 1,000 children in Africa are born with SCD every day and more than half die before they reach five years of age. Hence, swift treatment procedures for patients with SCD is needed. This factor is projected to accelerate the growth of the Kenya sickle cell disease treatment market in the years to come. The sickle cell disease treatment market is anticipated to attract investments from new avenues over the forthcoming years.

Market Drivers

Sickle cell disease market is driven by the increasing prevalence of sickle cell disease in low- and middle-income countries like Kenya. In addition, increasing product pipeline for treating sickle cell anaemia is expected to create high demand for these treatment options. Sickle cell anaemia treatment market is driven by increasing governments and regulatory bodies support by means of research and development investment, fast track approval for discovering newer treatments for this disorder.

More than 25 000 children were screened for SCD between 2012-2019 using isoelectric focusing, and of those found to have SCD, approximately 75% started treatment. At the same time, 1559 clinicians and other health care providers have been trained on how to manage SCD. County authorities have worked together with advocacy groups as well as clinicians in an effort to improve access to care and close gaps in knowledge within communities.

1. Kenya Sickle Cell Disease Market Overview………………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rise in Prevalence of Sickle Cell Disease in Kenya
B. Growing R&D Investments and Reimbursement Policies
C. Increase in Screening of SCD among Children
D. Increase in Training Imparted to Healthcare Professionals to Manage SCD
3. Major Sickle Cell Disease Types……………………………………………………………….
C. HbS beta-thalassemia
D. Sickle Cell Trait
4. Sickle Cell Disease Market Segmentation………………………………………….
A. Drug Class
I. Anti-Metabolites
II. Monoclonal Antibody
III. Others
B. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online
IV. Others
5. Sickle cell Disease Major Drugs Market Share………………………………..
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Novartis AG Company overview, Product & Services, Strategies & Financials
B. Pfizer, Inc. Company overview, Product & Services, Strategies & Financials
C. Bristol-Myers Squibb Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………….
A. New Trends and Development of Sickle cell drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

On the basis of drug class, the sickle cell disease drugs market in Kenya can be segmented into Anti-metabolites and Monoclonal Antibodies.

Hydroxyurea (Hydrea) is a medication that helps to prevent formation of sickle shaped red blood cells.

Crizanlizumab-tmca is a monoclonal antibody medication that helps to prevent Vaso-Occlusive Crisis in patients with sickle cell disease.

By Disease Indication:

Based on disease indication, Kenya sickle cell drugs market can be segmented into HbSS, HbSC, HbS beta-thalassemia and sickle cell trait. HbSS and HbSβ0 are the most severe forms of SCD, while HbSC and HbSβ+ are generally milder diseases

By Distribution Channel:

Based on distribution channels, the market can be segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.

Retail Pharmacies segment holds the largest contribution and is expected to witness high growth rate during the forecast period.

Major Players

Sickle Cell Disease Treatment market appears to be fragmented and with the presence of several companies including Novartis and Pfizer the competitive environment is quite intense. Factors such as the high prevalence of sickle cell disease and the strong pipeline of drugs, will provide considerable growth opportunities to sickle cell disease treatment manufactures. Cipla Limited, Bristol-Myers Squibb, Novartis, and Pfizer are some of the major companies.

Droxia, manufactured by Bristol-Myers Squibb is among the leading drug sold for sickle cell disease treatment in Kenya.

Hydroxyurea, sold under the brand name Cytodrox my Cipla Limited is one of the most efficient drugs sold in the sickle cell anaemia drug market in Kenya.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements